Diffuse hair loss

This is an increased hair loss in the area of the entire hairy head.

Various causes are known for the premature transition of the hair from the growth phase (anagen phase) to the loss phase (telogen phase), e.g:

febrile infections, viral infections
protein, iron or vitamin deficiencies
Hormonal imbalances in women (pregnancy/birth, menopause)
liver diseases
serious operations

Stress, hectic pace, high workload and psychological pressure are further examples of common causes that are currently becoming increasingly important.

Diffuse hair loss naturally recedes once the cause has been eliminated. In many cases, however, the cause is unknown and the hair loss often persists for many years.

99%

Reduction of hair loss in an average of 99% of women and men*.

76% - 93%

Improvement of seborrhea and erythema in at least 93% of women and 76% of men.

Typical course

If hair loss is persistent and severe, the entire hair becomes thinner and thinner.

Alopecia diffusa progression with THYMUSKIN^® treatment

Before ^**

After ^**

Before ^**

After ^**

Innovative GKL-02 Thymic Peptide Complex

The biological activity of thymuskin is particularly evident in the activation of hair cells (keratinocytes), which have a decisive influence on hair growth. Hair formation is stimulated.

THYMUSKIN^® Sensitive

For diffuse hair loss, we recommend the use of Thymuskin Sensitive Serum Gel and the Thymuskin Shampoo best suited to your hair type. Use for at least 3-6 months.

Thymuskin Sensitive Serum Gel has been specially developed for use in cases of severe hair loss and sensitive or dry scalps.

To the product finder

Results of clinical tests

Multicenter study

In a multicenter study*, the efficacy and tolerability of Thymuskin (serum and shampoo) was investigated in 184 women and 57 men with chronic telogen effluvium (chronic TE) over a period of 6 months.

* Barbareschi M. et al: Multicenter study on the efficacy of a serum and a shampoo for topical application containing nature-identical thymus peptides for use in androgenetic hair loss and chronic telogen effluvium in women and men. Published in 2013 in the Journal of Plastic Dermatology (Issue 9, 2013 - ISSN 2035-0686)

** Prof. Dr. M. Hagedorn, Klinikum Darmstadt, 1991

*** Open application monitoring Thymuskin, Mannheim, 2019